Experimental studies in animal models of liver cancer have also shown that nonsteroidal anti-inflammatory drugs (NSAIDs), including both selective and non-selective COX-2 inhibitors, exert chemopreventive as well as therapeutic effects. Here, PTGS2 is linked to liver cancer.